S
ystemic lupus erythematosus (SLE) is a multis s system chronic autoimmune inflammatory diss s ease. SLE has been associated with numerous complement abnormalities including C1q deficiency. 1 Patients with SLE and C1q deficiency may have a ses s vere multisystem disease, including cutaneous lesions. 2, 3 Patients with antiphospholipid antibody syndrome often develop cutaneous ulcerations which mimic pyos s derma gangrenosum (PG), particularly leg ulcers, and similar lesions have rarely been reported in patients with SLE. 4, 5 We managed a young girl with familial SLE and C1q deficiency who developed progressive exs s tensive ulcerations that were consistent with pyoderma gangrenosum.
CASE
A 14smonthsold girl, a product of a fullsterm normal delivery with an uneventful pregnancy and normal postsnatal period, presented initially with diffuse puss s tules on the face and extremities. These lesions had bros s ken down and rapidly enlarged in size and had became ulcerative with discharge and crust formation. She had a history of intermittent fever and poor appetite, but no other systemic manifestations. All blood and surface swab cultures were negative. The patient was initially treated with various antibiotics without improvement. She had strong family history of SLE. The parents are firstsdegree relatives and healthy. The eldest sister, a 6s yearsold also had SLE that was diagnosed and followed in our hospital.
The physical examination revealed an irritable, afes s brile girl. Weight and height were at the 5th percens s tile. She had multiple ulcerative lesions involving the face, scalp, and both extremities (Figures 1, 2 ). There was oral mucosal ulceration, but no lymphadenopathy or hepatosplenomegly. She had bilateral knee arthris s tis. Other examinations were unremarkable. The inis s to a dilution of 1:320 (speckled pattern) with positive antisdsDNA at 156 U/mL (normal, 0s20 U/mL), but negative extractable nuclear antigens. However, her ans s tiphospholipid antibody profile was positive: anticars s diolipin IgM was 150 MPL (normal, 0s12.5 MPL), IgG 17.2 g/L (normal, 0s10 g/L) and antisß2 glycoprotein (IgG) was 48.4 SGU/mL (normal, 0s10 SGU/mL). She had low complement levels (C3 and C4) at 0.4 g/L and 0.06 g/L, respectively. Because of her extensive skin involvement, CH50 and C1q levels were done and were low at 5 U/mL (normal, 345s485 U/mL) and 55 mg/L (normal, 75s250 mg/L), respectively. Based on the oral ulceration, arthritis, the direct Coombs test positivity and high titers of ANA and antisdsDNA, the diagnosis of SLE was made.
She was started on daily intravenous methylpreds s nisolone (30 mg/kg/day) for 3 consecutive days. A few days later she showed improvement and she was diss s charged home on oral prednisone 1 mg/kg/day in 2 dis s vided doses and azathioprine 2 mg/kg/day. A few weeks later she was seen in the clinic with acs s tive disease. She was extremely irritable and had extens s sive skin lesions. The dose of prednisone was increased and azathioprine was changed to cyclosporine 2 mg/ kg/day. Afew months later she presented to the hospital with a highsgrade fever and progressive skin lesions with pus collection. She was admitted to the hospital and underwent incision and drainage. The wound culture grew Staphylococcus aureus and group A streptococcus. However, the blood culture was negative. She was treats s ed with antibiotics, intravenous methylprednisolone and intravenous immunoglobulin. The fever subsided and her condition improved, but the skin ulceration did not improve. Because of the disease progression, a skin biopsy was done, which showed dense pandermal inflammation, predominantly suppurative and extends s ing to the superficial subcutaneous fat (Figure 3 ). The inflammation was associated with focally degenerated collagen. A naked hair shaft was observed entrapped within this inflammation (Figure 4 ), which indicates a ruptured suppurative folliculitis component and is cons s sistent with PG. No basal cell vacuolization or thickens s ing of the basement membrane was noted. There was no vasculitis. Special stains for fungus, acid fast bacilli and bacteria were negative. According to these findings, she was diagnosed with PG.
A skin biopsy for direct immunofluorescence taken from the nonaffected area revealed fine granular and discontinuous deposits of IgM and C3 along the bases s ment membrane. Other immunoreacatants (IgG, IgA, C1q and fibrin) were negative, which was consistent with a background SLE. No deposits around dermal vessels were seen.
She was started on thalidomide for a few months without improvement. Apparently her disease was pros s gressing. Ultimately we changed thalidomide to inflixs s imab. She received four doses but unfortunately there was rapid deterioration in her skin lesions and she had a secondary bacterial infection. She was admitted to the local hospital with septic shock due to gramsnegative sepsis and died.
DISCUSSION
PG usually begins as single or multiple pustules that rapidly progress to form ugly ulcerations. It is an idios s pathic inflammatory ulcerative dermatosis that is coms s monly associated with inflammatory bowel disease. However, it has been reported in association with other systemic diseases such as Behcet disease and in adult pas s tients with SLE, particularly in those with antiphosphos s lipid antibody syndrome. 4, 5 C1q deficiency is one of the rare immune deficiency disorders. It may be associated with infection. Patients with C1q deficiency are at risk of developing autoimmune diseases, including SLE, and they may have unusual manifestations. 1, 6 We report a child with SLE and C1q deficiency mans s ifesting with severe cutaneous ulceration that proved to be consistent with PG. To the best of our knowledge, there is no previous report of PG in children with SLE. In our patient, the diagnosis of SLE was based on the presence of constitutional symptoms, oral ulceration, ars s thritis, direct Coombs test positivity and a high titer of ANA and antisdsDNA, low C3, C4 and C1q levels and a strong family history of SLE. The possibility of cons s comitant infection as a contributing factor was highly suspected; accordingly, she was given broad spectrum ans s tibiotics. The rapidly progressive cutaneous ulcerations in the presence of antiphospholipid antibodies and poor response to conventional treatment raised the possibils s ity of PG, which was confirmed by the histopathologic findings and exclusion of the infectious causes.
The pathogenesis of PG remains unclear, but abs s normalities of the immune system have been described including defective neutrophil chemotaxis and phagocys s tosis. 7 In a large series of the patients with PG, half had immune complex deposition along the endothelial wall, which suggested a vasculitic etiology. 8 We believe that SLE in patients with C1q deficiency has unusual manifestations. 2, 9 The treatment of PG consists of corticosteroids, immunomodulating agents and recently, biologic agents. Although it is nonsspes s cific, the outcome is favorable. 10 Unfortunately, despite the intensive therapy our patient had a fatal outcome.
In conclusion, PG is a rare complication of lupus in children. Therapeutic intervention may not be helpful in severe cases.
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